ST-elevation acute myocardial infarction and clinical outcomes treated by optical coherence tomography-guided percutaneous coronary intervention (ATLAS-OCT Study)

ST-elevation acute myocardial infarction and clinical outcomes treated by optical coherence tomography-guided percutaneous coronary intervention (ATLAS-OCT Study) - ATLAS-OCT Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048590

Enrollment

600

Registered

2022-08-04

Start date

2022-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-elevation acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 STEMI patient presenting within 24 hours of symptom onset and undergoing primary PCI 2 Willing and able to provide written informed consent 3 18 years old and more

Exclusion criteria

Exclusion criteria: 1 Patient participating in any other research that contradicts the result of this study

Design outcomes

Primary

Measure	Time frame
The achievement rate of OCT-guided primary PCI in patients with ST-elevation acute myocardial infarction who are indicated for primary percutaneous coronary intervention.	—

Secondary

Measure	Time frame
1 One-year rate of major adverse cardiovascular events (all-cause death, myocardial infarction or target vessel revascularization) 2 One-year rate of target vessel revascularization 3 The achievement rate of each step of OCT-guided primary PCI (assessment of etiology, stent sizing and stent optimization) 4 Stent expansion 5 Post-procedural OCT findings (edge dissection, reference lumen narrowing, malapposition, in-stent minimum lumen area, stent expansion, minimum stent area, intrastent plaque or thrombus protrusion) 6 Comparison of post-procedural OCT findings between patients assessed by Ultreon system and AptiVue system 7 Comparison of procedural characteristics between patients assessed by Ultreon system and AptiVue system 8 Comparison of clinical outcomes between patients assessed by Ultreon system and AptiVue system	—

Measure

Time frame

1 One-year rate of major adverse cardiovascular events (all-cause death, myocardial infarction or target vessel revascularization) 2 One-year rate of target vessel revascularization 3 The achievement rate of each step of OCT-guided primary PCI (assessment of etiology, stent sizing and stent optimization) 4 Stent expansion 5 Post-procedural OCT findings (edge dissection, reference lumen narrowing, malapposition, in-stent minimum lumen area, stent expansion, minimum stent area, intrastent plaque or thrombus protrusion) 6 Comparison of post-procedural OCT findings between patients assessed by Ultreon system and AptiVue system 7 Comparison of procedural characteristics between patients assessed by Ultreon system and AptiVue system 8 Comparison of clinical outcomes between patients assessed by Ultreon system and AptiVue system

—

Countries

Japan

Contacts

Public ContactMyong Hwa Yamamoto

Showa University Clinical Research Institute for Clinical Pharmacology and Therapeutics ATLAS-OCTStudy Secretariat

tactics@ofc.showa-u.ac.jp03-3300-5247

Outcome results